Iveric Bio, An Astellas Company, is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. At Iveric Bio we understand the critical importance of vision in the quality of life of patients.
View Top Employees from Iveric Bio, An Astellas CompanyWebsite | http://www.ivericbio.com |
Ticker | OPHT |
Revenue | $209 million |
Funding | $597.7 million |
Employees | 280 (249 on RocketReach) |
Founded | 2007 |
Phone | (212) 845-8200 |
Fax | (212) 845-8250 |
Technologies |
JavaScript,
HTML,
Google Analytics
+27 more
(view full list)
|
Category | Biotechnology Research, Drug Manufacturing & Research, Therapeutic Devices, Pharmaceuticals, Healthcare |
Competitors | Adverum Biotechnologies, Constellation Pharmaceuticals, A MorphoSys Company, GenSight Biologics, Leap Therapeutics, Visterra Inc. |
SIC | 283, 28 |
NAICS | 3254, 325, 325414, 32, 32541 |
Looking for a particular Iveric Bio, An Astellas Company employee's phone or email?
The Iveric Bio, An Astellas Company annual revenue was $209 million in 2023.
Keith Westby is the COO of Iveric Bio, An Astellas Company.
249 people are employed at Iveric Bio, An Astellas Company.
The NAICS codes for Iveric Bio, An Astellas Company are [3254, 325, 325414, 32, 32541].
The SIC codes for Iveric Bio, An Astellas Company are [283, 28].